University of Cincinnati
Alicia Heelan
The purpose this research is to compare two different standards of care for pain management and two different standards of care for local numbing medicine for breast cancer patients who will have a total mastectomy.
Mastectomy; Lymphedema
Breast Cancer
Bupivacain
Exparel
Intraoperative Pecs II block (IOB) & superior AT (EX or BP)
Preoperative Pecs II block (POB) & superior AT (EX or BP)
PHASE4
The purpose this research is to compare two different standards of care for pain management and two different standards of care for local numbing medicine for breast cancer patients who will have a total mastectomy. Standard of care intervention is preoperative PECS-II blocks versus Intraoperative Pectoral Blocks. The medication used are standard of care and include Bupivacaine and liposomal bupivacaine. Bupivacaine is FDA approved and indicated for the local or regional anesthesia or analgesia for surgery procedures and therapeutic procedures. Liposomal bupivacaine is FDA approved and indicated for adults to produce postsurgical local analgesia and as nerve block to produce postsurgical regional analgesia.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 100 participants |
Masking : | NONE |
Primary Purpose : | SUPPORTIVE_CARE |
Official Title : | Post-mastectomy Recovery: A Randomized Clinical Trial Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks |
Actual Study Start Date : | 2024-09-01 |
Estimated Primary Completion Date : | 2026-08-01 |
Estimated Study Completion Date : | 2026-12-01 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
University of Cincinnati Medical Center
Cincinnati, Ohio, United States, 45219